Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 2, 2018
Fetal biometry to assess the size and growth of the fetusNeil O'Gorman, Laurent J Salomon
Women'S Health (London, England)|February 23, 2016
The use of ultrasound and other markers for early detection of preeclampsiaNeil O'Gorman, Kypros H Nicolaides, Liona C Y Poon
Archives of Gynecology and Obstetrics|January 22, 2010
Clinico-pathological study of cervical polypsSeema Anushka Tirlapur, Adewale Adeyemo, Neil O'Gorman, et al.
International Journal of Women'S Health|December 26, 2023
Preterm Birth: Screening and PredictionLyndsay Creswell, Daniel Lorber Rolnik, Stephen W Lindow, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|May 6, 2016
Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 yearMaryam Parisaei, Jane Currie, Neil O'Gorman, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 11, 2022
Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatmentDavid Wright, Min Yi Tan, Neil O'Gorman, et al.
BMJ Open|June 30, 2016
Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)Neil O'Gorman, David Wright, Daniel L Rolnik, et al.
International Journal of Women'S Health|February 23, 2023
Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future StepsLyndsay Creswell, Neil O'Gorman, Kirsten Rebecca Palmer, et al.
American Journal of Obstetrics and Gynecology|December 27, 2023
Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancyDaniel L Rolnik, Argyro Syngelaki, Neil O'Gorman, et al.
Prenatal Diagnosis|September 4, 2019
Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high risk of preterm pre-eclampsiaAna V Nikčević, Zoe Dodd, Jess Prior, et al.
Pageof 3